Alto Neuroscience
ANRO
ANRO
110 hedge funds and large institutions have $602M invested in Alto Neuroscience in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 43 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.17% more ownership
Funds ownership: 78.82% → 83.99% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
37% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 43
Holders
110
Holding in Top 10
3
Calls
$10.4M
Puts
$364K
Top Buyers
| 1 | +$20.4M | |
| 2 | +$16.7M | |
| 3 | +$9.27M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$9.27M |
| 5 |
Jennison Associates
New York
|
+$7.16M |
Top Sellers
| 1 | -$20.5M | |
| 2 | -$11.6M | |
| 3 | -$7.8M | |
| 4 |
Alkeon Capital Management
New York
|
-$4.63M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$4.52M |
